|Articles|April 12, 2016
OmniComm Penetrates Growing Israeli Life Sciences Market
Advertisement
TrialMaster® EDC selected by leading Israeli data management and biostatistics firm
Fort Lauderdale, FL, April 11, 2016 - OmniComm Systems, Inc., a global leading provider of clinical data management technology, today announced the signing an agreement with Medistat Ltd., a leading data management and biostatistics organization, headquartered in Tel Aviv, Israel. OmniComm’s TrialMaster electronic data capture (EDC) suite will be used to address the clinical trial needs of the growing Israeli life sciences sector which consists of more than 1300 organizations. “We are pleased that OmniComm Systems is realizing the value of the Israeli market and the position of Medistat as a global provider of data management and biostatistician solutions,” said Dr. Gil Harari President and CEO of Medistat, “We truly believe that the cooperation with OmniComm will be a key factor to becoming a leader in the rapidly growing Intelligent EDC market in Israel and worldwide.”
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5